New EPM Treatment Approved
On Nov. 19 the U.S. Food and Drug Administration (FDA) approved Navigator for treating equine protozoal myeloencephalitis (EPM). This drug has been under development for more than six years.
IDEXX Laboratories of Westbrook, Maine, received approval for the 32% nitazoxanide antiprotozoal oral paste designed to kill the single-celled protozoan parasite Sarcocystis neurona, which
